Aberrant expressions of leptin and adiponectin receptor isoforms in chronic myeloid leukemia patients

Cytokine

Volumn 57, Issue 1, 2012, Pages 61-67

  Ozturk, Kamile ^a   Avcu, Ferit ^b   Ugur Ural, A ^b  

^a AKSARAY UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adiponectin receptors; Chronic myeloid leukemia; Leptin receptors

Indexed keywords

ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; IMATINIB; LEPTIN RECEPTOR; LEPTIN RECEPTOR RA; LEPTIN RECEPTOR RT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CASE-CONTROL STUDIES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PROTEIN ISOFORMS; RECEPTORS, ADIPONECTIN; RECEPTORS, LEPTIN; RNA, MESSENGER;

EID: 84155164477     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.10.004     Document Type: Article

References (37)

1. Kelesidis I., Kelesidis T., Mantzoros C.S. Adiponectin and cancer: a systematic review. Br J Cancer 2006, 94:1221-1225.
2. Barb D., Williams C.J., Neuwirth A.K., Mantzoros C.S. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 2007, 86:858-866.
3. Vona-Devis L., Rose D.P. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer 2007, 14:189-206.
4. Fantuzzi G., Faggioni R. Leptin in regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000, 68:437-446.
5. Hino M., Nakao T., Yamane T., Ohta K., Takubo T., Tatsumi N. Leptin receptor and leukemia. Leuk Lymphoma 2000, 36:457-461.
6. Sanchez-Margalet V., Martin-Romero C., Santos-Alvarez J., Goberna R., Najib S., Gonzalez-Yanes C. Role of leptin as an immunomodulator of blood mononuclear cells. Clin Exp Immunol 2003, 133:11-19.
7. Russo V.C., Metaxas S., Kobayashi K., Haris M., Werther A. Antiapoptotic effects of leptin in human neuroblastoma cells. Endocrinology 2004, 145:4103-4112.
8. Lapas M., Permezel M., Rice G.E. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/ 2. Endocrinology 2005, 146:3334-3342.
9. Miyazaki T., Bub J.D., Iwamoto Y. C-Jun NH2-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt. Biochim Biophys Acta 2008, 1782:593-604.
10. Tartaglia L.A. The leptin receptor. J Biol Chem 1997, 272:6093-6096.
11. Mikhail A.A., Beck E.X., Shafer A., Barut B., Gbur J.S., Zupancic T.J., et al. Leptin stimulates fetal and adult erythroid and myeloid development. Blood 1997, 89:1507-1512.
12. Konopleva M., Mikhail A., Estrov Z., Zhao S., Haris D., Sanchez-Williams G., et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptottic activities. Blood 1999, 93:1668-1676.
13. Nakao T., Hino M., Yamane T., Nishizawa Y., Morii H., Tatsumi N. Expression of leptin receptor in human leukaemic blast cells. Br J Haematol 1998, 1002:740-745.
14. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., et al. Adiponectin, a new member of family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions and macrophages. Blood 2000, 96:1723-1732.
15. Yamauchi T., Kamon J., Ito Y., Tsuchida A., Yokomizo T., Kita S., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
16. Avcu F., Ural A.U., Yi{dotless}lmaz M.I., Bingol N., Nevruz O., Caglar K. Association of plasma adiponectin concentration with chronic lymphocytic leukemia and myeloproliferative disease. Int J Hematol 2006, 83:254-258.
17. Petridou E., Mantzoros C.S., Dessypris N., Dikalioti S.K., Trichopoulos D. Adiponectin in relation in childhood myeloblastic leukaemia. Br J Cancer 2006, 94:156-160.
18. Matsubara M., Maruoka S., Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002, 147:173-180.
19. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002, 103:137-142.
20. Sessions J. Monitoring your patients with chronic myeloid leukemia. Am J Health Syst Pharm 2006, 63:5-9.
21. Mistry T., Digby J.E., Chen J., Desai K.M., Randeva H.S. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun 2006, 348:832-838.
22. Panayoula C.T., Papa V., Koukourava A., Economopoulos T., Tsigos C., Raptis S.A. Expression of leptin receptors in mononuclear cells from myelodysplastic syndromes and acute myeloid leukemias. Acta Haematol 2005, 114:71-77.
23. Mouzaki A., Panagoulias I., Dervilli Z., Zolota V., Spadidea P., Rodi M., et al. Expression patterns of leptin receptor (OB-R) isoform and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human hematopoietic malignant cells. Cytokine 2009, 48:203-211.
24. Panayoula C.T., Papa V., Raptis S.A., Tsigos C. Expression of the long and short leptin receptor isoform in peripheral blood mononuclear cells: implications for leptin's actions. Metabolism 2002, 49:1537-1541.
25. Sanchez-Margalet V., Martin Romero C., Gonzalez-Yanes C., Goberna J., Rodriguez-Bano J., Muniani M.A. Leptin receptor (Ob-R) expression is induced in peripheral blood mononuclear cells by in vitro activation and in vivo in HIV-infected patients. Clin Exp Immunol 2002, 129:119-124.
26. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanism. Nat Rev Cancer 2004, 4:579-591.
27. Wex H., Ponelis E., Wex T., Dressendörfer R., Mitler U., Vorwerk P. Plasma leptin and leptin receptor expression in childhood acute lymphoblastic leukemia. Int J Hematol 2002, 76:446-452.
28. Haluzik M., Markova M., Slaby J.J., Jiskra J., Krizova J., Haas T. The changes of serum leptin and soluble leptin receptor levels in patients undergoing mobilization of peripheral blood stem cells before autologous stem cells transplantaion. Endocrine 2002, 28:189-197.
29. Bruserud Q., Huang T.S., Glenjen N., Tore B., Foss B. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemic blasts. Haematologica 2002, 87:584-595.
30. Dalamaga M., Karmaniolas K., Panagiotou A., Hsi A., Chamberland J., Dimas C., et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Cancer Causes Control 2009, 20:193-199.
31. Moschovi M., Trimis G., Vounatsou M., Katsibardi K., Margeli A., Damianos A., et al. Serial plasma concentration of adiponectin, leptin, and resistin during therapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2010, 32:8-13.
32. Iversen P.O., Wiig H. Tumor necrosis factor and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis. Clin Cancer Res 2005, 11:6793-6799.
33. Cong L., Gasser J., Zhao J., Yang B., Li F., Zhao A.Z. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95-2. Endocr Relat Cancer 2007, 14:713-720.
34. Molica S., Vitelli G., Cutrona G., Todoerti K., Mirabelli R., Digiesi G., et al. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia. Int J Hematol 2008, 88:374-380.
35. Terence T.L. Pang and Parth Narendran. The distribution of adiponectin receptors on human peripheral blood mononuclear cells. Ann N Y Acad Sci 2008, 1150:143-145.
36. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocrine Reviews 2005, 26:439-451.
37. Yamauchi T., Nio Y., Maki T., Kobayashi M., Takazawa T., Iwabu M., et al. Target disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007, 13:332-339.